The lower apelin and nitric oxide levels in patients with hypertension and obesity or their reduction due to infection with COVID-19 or concomitant COVID-19 + diabetes mellitus may make them vulnerable to experiencing severe diseases. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.